Has Syed Waliuddin, MD received payments from drug or device companies?

Yes. Drug and device makers reported $32,136 in general payments to Syed Waliuddin, MD across 184 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Syed Waliuddin, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Syed Waliuddin, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Syed Waliuddin, MD

Psychiatry · Elgin, ILNPI 1104046630

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $27,125 of the $32,136 with a category attached, or 84.4%. AbbVie accounts for 85.3% of it on its own, with 17 other manufacturers making up the rest. Reporting peaked in 2019 at $12,398 and has fallen 99.6% since, to $47 in 2025. Among psychiatry clinicians in IL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$32,136in general payments, 2019–2025

Across 184 payments — averaging $174.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

AbbVie$27K
Supernus Pharmaceuticals, Inc.$3K
Neos Therapeutics, LP$724
Sunovion Pharmaceuticals Inc.$414
Tris Pharma Inc$273
Neurocrine Biosciences, Inc.$239
plus $524 from 12 others

What the payments were for

Consulting fees$5502%
Speaking & faculty fees$27,12584%
Travel & lodging$1,0083%
Food & beverage$3,45211%
Education$10%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
AbbVie(2 entities)	103	$27,398
Supernus Pharmaceuticals, Inc.	7	$2,564
Neos Therapeutics, LP	4	$724
Sunovion Pharmaceuticals Inc.	23	$414
Tris Pharma Inc	13	$273
Neurocrine Biosciences, Inc.	4	$239
Otsuka America Pharmaceutical, Inc.	5	$124
Lundbeck LLC	7	$115
Shire North American Group Inc	3	$50
Takeda Pharmaceuticals U.S.A., Inc.	4	$42
Vertical Pharmaceuticals, LLC	2	$34
Johnson & Johnson	2	$31
Bausch Health US, LLC	2	$30
Alkermes, Inc.	1	$29
Genentech USA, Inc.	1	$22
Indivior Inc.	1	$16
Avanir Pharmaceuticals, Inc.	1	$15
Teva Pharmaceuticals USA, Inc.	1	$15

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$32,136 in reported general payments places this provider in the 95th percentile of 1,344 psychiatry providers in Illinois.

See all psychiatry providers in Illinois →

Medicare billing

Part B allowed, 2024

$72,277

Medicare patients

172

Services billed

730

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Aripiprazole	69	$16,629
XanaxAlprazolam	12	$6,149
Duloxetine Hcl	262	$4,647
Modafinil	15	$3,774
Atomoxetine Hcl	16	$2,310
Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine	32	$1,895
Bupropion XlBupropion Hcl	97	$1,855
Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine	66	$1,707
Mirtazapine	92	$1,654
Alprazolam	220	$1,541
Escitalopram Oxalate	120	$1,537
Clonazepam	131	$1,524
Ziprasidone Hcl	24	$1,503
Desvenlafaxine Succinate ErDesvenlafaxine Succinate	19	$1,479
Olanzapine	28	$1,162

Paid to pharmacies, not to this prescriber.

Other psychiatry in Elgin

Syed AnwarElgin$20K
Michael FeldNorthbrook$1.1M
Jose MontesRockford$882K
Mitchell GlaserChicago$752K
Roukan JazayerliOrland Park$597K
Ming XuBourbonnais$505K
Peter WeidenChicago$440K
Michelle DeesChicago$289K
Mark ShukhmanSkokie$250K
Abid NazeerOak Brook$228K

See the full list for Illinois →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →